US Bone Spur Market Summary

As per Market Research Future analysis, the US bone spur market Size was estimated at 447.3 USD Million in 2024. The US bone spur market is projected to grow from 467.97 USD Million in 2025 to 735.12 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.6% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The US bone spur market is experiencing a notable shift towards non-surgical interventions driven by technological advancements and demographic changes.

The rising incidence of osteoarthritis is contributing to an increased demand for bone spur treatments.
Advancements in treatment technologies are enhancing the effectiveness of interventions for bone spurs.
The non-surgical intervention segment is currently the largest, reflecting a broader trend towards conservative treatment options.
Key market drivers include the aging population and increased awareness of bone health, which are likely to propel market growth.

Market Size & Forecast

2024 Market Size	447.3 (USD Million)
2035 Market Size	735.12 (USD Million)
CAGR (2025 - 2035)	4.62%

Major Players

DePuy Synthes (US), Stryker (US), Zimmer Biomet (US), Medtronic (US), Smith & Nephew (GB), Orthofix (US), NuVasive (US), Amedica Corporation (US)

Our Impact

Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals

Partnering with 2000+ Global Organizations Each Year

30K+ Citations by Top-Tier Firms in the Industry

US Bone Spur Market Trends

The bone spur market is currently experiencing notable developments driven by an aging population and increasing awareness of musculoskeletal disorders. As individuals age, the prevalence of conditions leading to bone spurs, such as osteoarthritis, tends to rise. This demographic shift is prompting healthcare providers to focus on early diagnosis and effective management strategies. Furthermore, advancements in medical technology are enhancing treatment options, leading to improved patient outcomes. The integration of minimally invasive procedures and innovative therapies is likely to reshape the landscape of care for those affected by bone spurs. In addition, the growing emphasis on preventive care and lifestyle modifications is influencing the bone spur market. Patients are increasingly seeking non-surgical interventions, such as physical therapy and orthotic devices, to alleviate symptoms. This trend reflects a broader shift towards holistic approaches in healthcare, where patients prioritize long-term wellness over immediate surgical solutions. As awareness continues to grow, the market is expected to evolve, with a focus on personalized treatment plans that cater to individual needs and preferences. Overall, the bone spur market appears poised for growth, driven by demographic changes and a shift towards patient-centered care.

Rising Incidence of Osteoarthritis

The increasing prevalence of osteoarthritis among the aging population is a key driver in the bone spur market. As this degenerative joint disease becomes more common, the likelihood of developing bone spurs rises, leading to greater demand for treatment options.

Advancements in Treatment Technologies

Innovations in medical technology are transforming the landscape of the bone spur market. Minimally invasive surgical techniques and new therapeutic modalities are enhancing patient outcomes, making treatments more accessible and effective.

Shift Towards Non-Surgical Interventions

There is a noticeable trend towards non-surgical management of bone spurs, with patients opting for physical therapy and orthotic solutions. This shift reflects a growing preference for conservative treatment approaches that prioritize long-term health.

US Bone Spur Market Drivers

Growing Prevalence of Obesity

The growing prevalence of obesity in the US is emerging as a significant driver for the bone spur market. Obesity is associated with various musculoskeletal disorders, including an increased risk of developing bone spurs. The Centers for Disease Control and Prevention reports that over 42% of adults in the US are classified as obese. This alarming statistic suggests a potential rise in demand for interventions targeting bone spurs, as healthcare providers address the complications arising from obesity. The bone spur market may experience growth as treatment options become more tailored to the needs of obese patients, including lifestyle modifications and surgical interventions. This correlation between obesity and bone health underscores the importance of addressing weight management in the context of bone spur treatment.

Rising Healthcare Expenditure

The rising healthcare expenditure in the US is a pivotal factor influencing the bone spur market. As healthcare spending continues to increase, patients are more likely to seek treatment for bone-related conditions, including bone spurs. According to the Centers for Medicare & Medicaid Services, national health spending is projected to grow at an average rate of 5.4% annually. This trend indicates a robust market environment for healthcare providers and manufacturers within the bone spur market. Increased funding for research and development may also lead to the introduction of new treatment options, further stimulating market growth. Consequently, the financial commitment to healthcare is likely to enhance the accessibility and availability of bone spur treatments.

Aging Population and Bone Health

The aging population in the US is a critical driver for the bone spur market. As individuals age, the likelihood of developing bone-related conditions, including bone spurs, increases significantly. According to the US Census Bureau, by 2030, approximately 20% of the population will be 65 years or older. This demographic shift suggests a growing demand for treatments and interventions related to bone health. The bone spur market is likely to experience heightened activity as healthcare providers seek to address the needs of this aging cohort. Furthermore, the increased prevalence of osteoarthritis and other degenerative joint diseases among older adults may further contribute to the demand for effective management solutions in the bone spur market.

Increased Awareness of Bone Health

There is a notable increase in awareness regarding bone health among the US population, which serves as a significant driver for the bone spur market. Educational campaigns and health initiatives have emphasized the importance of maintaining bone density and preventing conditions such as bone spurs. This heightened awareness is likely to lead to more individuals seeking medical advice and treatment options for bone-related issues. As a result, the bone spur market may see a surge in demand for diagnostic tools and therapeutic interventions. Additionally, the growing trend of preventive healthcare could encourage individuals to pursue early interventions, thereby expanding the market for bone spur treatments.

Technological Innovations in Diagnostics

Technological advancements in diagnostic imaging and treatment modalities are transforming the bone spur market. Innovations such as MRI and CT scans enable healthcare professionals to accurately diagnose bone spurs and assess their severity. This precision in diagnosis is crucial for developing effective treatment plans. Moreover, the introduction of minimally invasive surgical techniques and advanced orthopedic devices is likely to enhance patient outcomes. The bone spur market is expected to benefit from these technological innovations, as they may lead to increased patient satisfaction and reduced recovery times. As healthcare providers adopt these advanced technologies, the demand for related products and services in the bone spur market is anticipated to grow.

Market Segment Insights

By Type: Calcaneal Spur (Largest) vs. Spinal Spur (Fastest-Growing)

In the US bone spur market, the Calcaneal Spur segment holds a significant portion of the market share, driven by the high prevalence of heel pain among the population. Following closely, the Spinal Spur segment is gaining traction, with increasing awareness and diagnosis of spinal issues contributing to its growth. Other segments such as Shoulder Spur and Hip Spur continue to emerge but currently hold a smaller market share. The growth trends within the segment indicate a robust expansion for the Spinal Spur as more patients seek specialized treatments for back pain. The increasing elderly demographic and advancements in surgical techniques are amplifying the demand for effective solutions in this segment. Meanwhile, the established Calcaneal Spur segment benefits from a well-structured treatment landscape, yet it faces challenges from emerging alternatives.

Calcaneal Spur (Dominant) vs. Spinal Spur (Emerging)

The Calcaneal Spur segment is characterized by its dominance in the US bone spur market due to the high incidence of plantar fasciitis and related conditions. It represents a well-defined set of treatment options ranging from conservative management to surgical intervention. In contrast, the Spinal Spur segment is emerging rapidly, fueled by advances in medical technology and a greater understanding of spine-related issues. This segment encompasses various approaches, including minimally invasive procedures, which appeal to patients seeking effective and less invasive solutions. Both segments play crucial roles in the overall market, yet they cater to distinct patient needs and treatment strategies.

By Treatment Type: Non-surgical Treatment (Largest) vs. Surgical Treatment (Fastest-Growing)

In the US bone spur market, Non-surgical Treatment dominates, holding a significant share amidst varying approaches for managing this condition. The preference for less invasive solutions reflects a broader trend towards conservative management strategies, which emphasize recovery without the need for surgical intervention. In contrast, Surgical Treatment, while initially less favored, is rapidly gaining market traction due to advancements in surgical techniques and increasing awareness among patients about effective surgical options available. Growth trends in the treatment type segment are driven by several factors. The rising incidence of bone spur cases necessitates effective treatment strategies, leading to a steady demand for both Non-surgical and Surgical Treatments. Additionally, Physical Therapy and Medication play pivotal roles in managing symptoms, further fueling segment expansion as patients seek comprehensive care. The emergent preference for personalized medicine is also shaping treatment modalities, directing focus towards techniques that minimize recovery time and optimize patient outcomes.

Non-surgical Treatment: Dominant vs. Surgical Treatment: Emerging

Non-surgical Treatment remains the cornerstone of care in the US bone spur market, characterized by accessible options such as lifestyle modifications and physiotherapy. This segment appeals to a wide demographic, prioritizing patient comfort and safety while effectively managing symptoms. With a plethora of advancements, Non-surgical options leverage modern technologies and techniques, enhancing recovery without invasive procedures. On the other hand, Surgical Treatment has made significant strides, emerging as a viable alternative for chronic cases. Patients are increasingly opting for surgical approaches due to improved outcomes and reduced hospital stays. Enhanced surgical methodologies and postoperative care have made this segment more attractive, driving its growth and adoption.

By End User: Orthopedic Clinics (Largest) vs. Hospitals (Fastest-Growing)

In the US bone spur market, the distribution of market share among the end user segments reveals that orthopedic clinics hold the largest share, primarily due to their specialized focus on musculoskeletal disorders. Rehabilitation centers also play a vital role, although their share is smaller, as many patients are referred to these facilities after initial treatment. Growth trends indicate that hospitals are emerging as the fastest-growing segment, driven by advancements in surgical techniques and an increase in outpatient procedures. The rising prevalence of bone spur-related conditions, along with an aging population seeking effective treatments, continues to propel demand across all segments. Additionally, technological innovations and improved healthcare policies are expected to further enhance the capabilities of hospitals and clinics alike.

Orthopedic Clinics (Dominant) vs. Rehabilitation Centers (Emerging)

Orthopedic clinics dominate the US bone spur market due to their dedicated services that cater specifically to patients with bone-related issues. They offer a range of treatments, from conservative management to surgical interventions tailored to individual needs. The personalized care and expertise in handling complex cases make them a preferred choice for patients. Meanwhile, rehabilitation centers are emerging as vital components in the treatment ecosystem, focusing on recovery and rehabilitation post-surgery or conservative treatment. These centers prioritize patient outcomes through targeted therapies and support services, thereby filling a crucial gap in the continuum of care for individuals suffering from bone spurs.

By Patient Demographics: Aged 51-65 (Largest) vs. Aged 36-50 (Fastest-Growing)

In the US bone spur market, the age group of 51-65 represents the largest share, indicating a significant prevalence of bone spur conditions among middle-aged individuals. This segment's majority share reflects the generally higher incidence of musculoskeletal issues as populations age, leading to increased diagnostic and intervention rates. Meanwhile, the 36-50 age range has emerged as the fastest-growing segment, likely due to increasing awareness of healthcare issues related to bone health in this demographic, contributing to rising demand for treatment options. The growth trends for the US bone spur market highlight a proactive approach among younger patients, particularly those in the 36-50 age group. This demographic is increasingly seeking medical advice for preventative measures and early interventions, incentivized by better access to healthcare information and advancements in medical technology. The proactive nature of this segment indicates a shift towards early diagnosis and management, hinting at potential changes in healthcare strategies as more individuals take charge of their musculoskeletal health.

Aged 51-65 (Dominant) vs. Aged 36-50 (Emerging)

The Aged 51-65 segment is characterized by a high prevalence of bone spur conditions, often resulting from cumulative wear and tear in a population that is becoming increasingly aware of their health needs. This group typically engages more with healthcare providers, leading to higher diagnosis rates and treatment initiatives. In contrast, the Aged 36-50 segment is emerging rapidly, fueled by greater health awareness and advocacy for early intervention. Younger patients in this range display a willingness to explore various treatment options, including minimally invasive procedures, making them a crucial target for healthcare providers aiming to improve patient engagement and outcomes in the US bone spur market.

Get more detailed insights about US Bone Spur Market

Request Free Sample

Key Players and Competitive Insights

The bone spur market exhibits a competitive landscape characterized by a blend of innovation, strategic partnerships, and regional expansion. Key players such as DePuy Synthes (US), Stryker (US), and Zimmer Biomet (US) are at the forefront, each employing distinct strategies to enhance their market presence. DePuy Synthes (US) focuses on innovation through advanced surgical solutions, while Stryker (US) emphasizes digital transformation and the integration of AI in surgical procedures. Zimmer Biomet (US) is actively pursuing mergers and acquisitions to bolster its product portfolio, thereby shaping a competitive environment that is increasingly dynamic and responsive to technological advancements.In terms of business tactics, companies are localizing manufacturing to reduce lead times and optimize supply chains, which is crucial in a moderately fragmented market. The collective influence of these key players fosters a competitive structure that encourages innovation and responsiveness to market demands. This localized approach not only enhances operational efficiency but also aligns with the growing consumer preference for rapid access to medical solutions.

In October Stryker (US) announced a strategic partnership with a leading AI technology firm to develop predictive analytics tools for surgical outcomes. This move is significant as it positions Stryker at the cutting edge of surgical technology, potentially improving patient outcomes and operational efficiencies. The integration of AI into surgical practices may redefine standards of care and operational protocols in the bone spur market.

In September Zimmer Biomet (US) completed the acquisition of a smaller orthopedic device company, which is expected to enhance its product offerings in the bone spur segment. This acquisition reflects a strategic focus on expanding its market share and diversifying its product line, thereby reinforcing its competitive position. Such strategic maneuvers are indicative of a broader trend where companies seek to consolidate their market presence through targeted acquisitions.

In August DePuy Synthes (US) launched a new line of minimally invasive surgical instruments designed specifically for bone spur removal. This product introduction not only showcases the company's commitment to innovation but also addresses the growing demand for less invasive surgical options. The emphasis on minimally invasive techniques is likely to resonate well with both healthcare providers and patients, potentially driving market growth.

As of November current trends in the bone spur market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing their technological capabilities. Looking ahead, competitive differentiation is expected to evolve, shifting from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition underscores the importance of agility and responsiveness in a rapidly changing market landscape.

Key Companies in the US Bone Spur Market include

Industry Developments

The US Bone Spur Market has seen significant developments in recent months, particularly concerning key players like Smith and Nephew, Integra LifeSciences, and Stryker Corporation. Recent advancements in treatment techniques and device innovations have driven market growth, focusing on minimally invasive surgeries and improved patient outcomes.

There has also been an increasing awareness of bone spur issues among the aging population, contributing to a higher demand for effective treatment solutions. Notably, in July 2023, Acumed announced a strategic partnership with a leading orthopedic hospital network to streamline patient access to their bone spur management products.

In June 2023, Medtronic expanded its product lines with new implants designed for better bone spur resolution, showcasing the ongoing innovation in the field. The bone spur market has seen a valuation increase, driven by higher adoption rates of advanced technologies. In terms of mergers and acquisitions, in August 2023, Zimmer Biomet acquired a small orthopedic device company specializing in bone spur solutions to broaden its product portfolio and market reach, reflecting a trend towards consolidation within the bone health sector. Overall, these trends indicate a dynamic and evolving market landscape focused on enhancing patient care and treatment efficacy.

Future Outlook

US Bone Spur Market Future Outlook

The Bone Spur Market is projected to grow at 4.62% CAGR from 2025 to 2035, driven by increasing prevalence of musculoskeletal disorders and advancements in treatment options.

New opportunities lie in:

Development of minimally invasive surgical techniques for bone spur removal.
Expansion of telehealth services for remote patient monitoring and consultations.
Investment in regenerative medicine technologies to enhance recovery and reduce recurrence.

By 2035, the bone spur market is expected to achieve substantial growth, reflecting evolving treatment paradigms and patient needs.

Market Segmentation

US Bone Spur Market Type Outlook

Calcaneal Spur
Spinal Spur
Shoulder Spur
Hip Spur

US Bone Spur Market End User Outlook

Hospitals
Orthopedic Clinics
Rehabilitation Centers

US Bone Spur Market Treatment Type Outlook

Non-surgical Treatment
Surgical Treatment
Physical Therapy
Medication

US Bone Spur Market Patient Demographics Outlook

Aged 18-35
Aged 36-50
Aged 51-65
Aged 65 and above

Report Scope

MARKET SIZE 2024	447.3(USD Million)
MARKET SIZE 2025	467.97(USD Million)
MARKET SIZE 2035	735.12(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	4.62% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Million
Key Companies Profiled	DePuy Synthes (US), Stryker (US), Zimmer Biomet (US), Medtronic (US), Smith & Nephew (GB), Orthofix (US), NuVasive (US), Amedica Corporation (US)
Segments Covered	Type, Treatment Type, End User, Patient Demographics
Key Market Opportunities	Advancements in minimally invasive surgical techniques enhance treatment options in the bone spur market.
Key Market Dynamics	Rising demand for minimally invasive treatments drives innovation and competition in the bone spur market.
Countries Covered	US

FAQs

What was the overall market valuation of the US bone spur market in 2024?

The overall market valuation was $447.3 Million in 2024.

What is the projected market valuation for the US bone spur market by 2035?

The projected market valuation for 2035 is $735.12 Million.

What is the expected CAGR for the US bone spur market during the forecast period 2025 - 2035?

The expected CAGR for the US bone spur market during the forecast period 2025 - 2035 is 4.62%.

Which segment had the highest valuation in 2024 for the US bone spur market?

The Hip Spur segment had the highest valuation at $240.12 Million in 2024.

What are the key treatment types in the US bone spur market?

Key treatment types include Non-surgical Treatment, Surgical Treatment, Physical Therapy, and Medication.

What was the valuation for Non-surgical Treatment in 2024?

The valuation for Non-surgical Treatment was $250 Million in 2024.

Which age demographic is projected to have the highest market valuation by 2035?

The Aged 65 and above demographic is projected to have the highest market valuation at $255.12 Million by 2035.

What is the market valuation for Rehabilitation Centers in 2024?

The market valuation for Rehabilitation Centers was $288.88 Million in 2024.

Who are the key players in the US bone spur market?

Key players include DePuy Synthes, Stryker, Zimmer Biomet, Medtronic, Smith & Nephew, Orthofix, NuVasive, and Amedica Corporation.

What was the valuation for the Spinal Spur segment in 2024?

The valuation for the Spinal Spur segment was $190 Million in 2024.

Author

Author

Satyendra Maurya

Research Analyst

An accomplished research analyst with high proficiency in market forecasting, data visualization, competitive benchmarking, and others. He holds a pronounced track record in research and consulting projects for sectors such as life sciences, medical devices, and healthcare IT. His capabilities in qualitative and quantitative analysis have resulted in positive client outcomes. Working on niche market trends, opportunities, sales, and forecasted value is part of his skill set.

Co-Author

Garvit Vyas

Vice President - Operations

Garvit Vyas is a Research Analyst with experience in working across multiple industry domains in the market research sector. Over the past four years, he has been actively involved in analyzing diverse markets, gathering industry insights, and contributing to the development of comprehensive research reports. His work includes studying market trends, evaluating competitive landscapes, and supporting data-driven business insights. In the early phase of his career, Garvit worked on cross-domain research projects, which helped him build a strong foundation in market analysis, data interpretation, and industry intelligence across various sectors. Later, he transitioned into the Quality Control (QC) function, where he focuses on reviewing and refining research reports and marketing collaterals to ensure accuracy, consistency, and high editorial standards. His responsibilities include validating research data, improving report structure, and maintaining the overall quality of published content. Garvit is committed to maintaining strong research integrity and delivering reliable insights that support informed business decision-making.

Get In Touch

Leave a Comment